Jolanda van der Velden

PROF.DR., (Principal Investigator)


Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile


Sarcomere, Muscle physiology, Cardiomyopathy, Hypertrophy, Heart Failure

Research interests

I am chair of the Department of Physiology at the Amsterdam University Medical Center, and director of the Amsterdam Cardiovascular Sciences Institute. At a national level, I actively participate in the Dutch Cardiovascular Alliance (DCVA) as Chair of the Talent program.

My main research interest is the role of sarcomeric proteins in cardiac performance, both in health and disease. As mutations in sarcomeric proteins are a frequent cause of heart disease, research on inherited cardiomyopathies is a central research line in Amsterdam UMC. My team at the Physiology department collaborates with clinical geneticists, cardiologists, cardiac surgeons and experts in in vivo cardiac imaging, enabling translational studies from bench to the patient.

Our expertise includes functional studies at single cardiac muscle cell and multicellular level, and mitochondrial studies in patient samples obtained during cardiac surgery, and stem cell-derived  heart models. Our translational studies in human are complemented with studies in a cardiomyopathy mouse model. Recent collaboration with CytoCypher enables high-throughput studies in (stem cell-derived) cardiomyocytes (compound screening, effects of disease modifiers).
Our current research projects aim to define the role of mitochondrial dysfunction in onset of cardiac disease, metabolic stress (obesity) as secondary disease hit, and protein homeostasis with a focus on the microtubular network. The research is funded by a VICI, ZonMW-Heart Foundation translational research grant (ENERGY trial), LeDucq foundation, and a DCVA consortium grant (Heart Foundation and Stichting Hartedroom; Dosis consortium; Double-Dose research program).


Recent external collaboration on country/territory level. Dive into details by clicking on the dots or